Development and validation of an HPLC-MS/MS method for the analysis of dexamethasone from pig synovial fluid using dried matrix spotting

Bioanalysis

Volumn 2, Issue 11, 2010, Pages 1829-1837

  Christianson, Chad D ^a   Laine, Derek F ^a   Zimmer, Jennifer S D ^a   Johnson, Casey J L ^a   Sheaff, Chrystal N ^a   Carpenter, Anna ^a   Needham, Shane R ^a  

^a Alturas Analytics Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; COLORING AGENT;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRIED MATRIX SPOT TECHNIQUE; DRUG DETERMINATION; DRUG STABILITY; DRUG SYNOVIAL FLUID LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; QUALITY CONTROL; SWINE; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; ANIMAL; CHEMISTRY; COLOR; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; METHODOLOGY; STANDARD; SYNOVIAL FLUID;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLOR; COLORING AGENTS; DEXAMETHASONE; DRUG STABILITY; REFERENCE STANDARDS; SPECIMEN HANDLING; SWINE; SYNOVIAL FLUID; TANDEM MASS SPECTROMETRY;

EID: 79952529661     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.137     Document Type: Article

References (27)

1. Spooner N, Rakesh L, Barfeld M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal Chem. 81(4), 1557-1563 (2009).
2. Déglon J, Thomas A, Cataldo A, Mangin P, Staub C On-line desorption of dried blood spot: a novel approach for the direct LC/MS ana lysis of μ-whole blood samples. J. Pharmacuet. Biomed. 49, 1034-1039 (2009).
3. Rowland M, Emmons G. Use of dried blood spots in drug development: pharmacokinetic considerations. AAPS J. 12(3), 290-293 (2010).
4. Abu-Rabie Paul, Spooner N. Direct quantitative bioanalysis of drugs in dried blood spot samples using a thin-layer chromatography mass spectrometer interface. Anal. Chem. 81(24), 10275-10284 (2009).
5. Heine RT, Rosing H, van Gorp ECM et al. Quantifcation of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry. J. Chromatogr. B 867(2), 205-212 (2008).
6. Déglon J, Lauer E, Thomas A, Mangin P, Staub C Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fuoxetine, norfuoxetine, reboxetine, and paroxetine analysis. Anal. Bioanal. Chem. 396(7), 2523-2532 (2010).
7. Li W, Tse FLS. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24, 49-65 (2010).
8. Saracino MA, Gerra G, Somani L, Colombati M, Raggi A. Chromatographic analysis of serotonin, 5-hydroxyindolacetic acid and homovanillic acid in dried blood spots and platelet poor and rich plasma samples. J. Chromatogr. B 1217(29,) 4808-4814 (2010).
9. Oglesbee D, Sanders KA, Lacey JM et al. Second-tier test for quantifcation of allosoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD). Clin. Chem. 54, 542-549 (2008). (Pubitemid 351348164)
10. O'Broin S, Gunter EW. Screening of folate status with use of dried blood spots on flter paper. Am. J. Clin. Nutr. 70(3), 359-367 (1999). (Pubitemid 29407156)
11. Gupta R, Abraham RA, Dhatwalia S, Ramakrishnan L, Prabhakaran D, Reddy KS. Use of dried blood for measurement of trans fatty acids. Nutr. J. 8(35), 1-5 (2009).
12. Christianson C, Johnson C, Zimmer J, Needham S. Dried blood spot analysis-utilizing the technique to develop assays in rare or limited matrices. Proceedings of: The American Society of Mass Spectrometry Conference. Salt Lake City, UT, USA May 2010.
13. Knox P, Levick JR, McDonald JN. Synovial fuid-its mass, macromolecular content and pressure in major limb joints of the rabbit. Q. J. Exp. Physiol. 73, 33-45 (1988). (Pubitemid 18028553)
14. Georgakopoulos CD, Lamari FN, Karathanasopoulou IN, Gartaganis VS, Pharmakakis NM, Karamanos NK. Tear analysis of ascorbic acid, uric acid and malondialdehyde with capillary electrophoresis. Biomed. Chromatogr. 24(8), 852-857 (2009).
15. Liu L, Duff K. A technique for serial collection of cerebrospinal fuid from the cisterna magna in mouse. J. Vis. Exp. 10(21), 960 (2008)
16. van den Berg MP, Romeijn SG, Verhoef JC, Merkus FWHM. Serial cerebrospinal fuid sampling in a rat model to study drug uptake from the nasal cavity. J. Neurosci. Meth. 116, 99-107 (2002). (Pubitemid 34465788)
17. Damonte G, Salis A, Rossi L, Magnani M, Benatti U. High-throughput HPLC-ESI-MS method for the quantitation of dexamethasone in blood plasma. J. Pharmaceut. Biomed. 43, 376-380 (2007). (Pubitemid 44856211)
18. Cherlet M, De Baere S, Croubels S, De Backer P. quantitative determination of dexamethasone in bovine plasma and tissues by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry to monitor residue depletion kinetics. Anal. Chim. Acta. 529, 361-369 (2005). (Pubitemid 40164335)
19. Yang Y, Li H, Gao K et al. simultaneous quantitation of dexamethasone palmitate and dexamethasone in human plasma by liquid chromatography/tandem mass spectrometry. J. Chromatogr. B 862, 119-124 (2008).
20. Stein A, Yassouridis A, Szopko C, Helmke K, Stein C Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 83(3), 525-532 (1999).
21. Odio C, Ramirez T, Aria G et al. Double blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. Pediatr. Infect. Dis. J. 22(10), 883-889 (2003).
22. Ahluwalia A. Topical glucocorticoids and the skin-mechanisms of action: an update. Mediat. Infamm. 7, 183-193 (1998). (Pubitemid 28338148)
23. Girault J, Istin B, Fourtillan JB. A rapid and highly sensitive method for the quantitative determination of dexamethasone in plasma, synovial fuid and tissues by combined gas chromatography/negativeion chemical ionization mass spectrometry Biol. Mass Spectrom. 19(5), 295-302 (2005).
24. Scot RC, Dick IP. Pig ear skin as an in-vitro model for human skin permeability J. Pharm. Pharmacol. 44(8), 640-645 (1992)
25. US Department of Health and Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry. Bioanalytical Method Validation. Rockville MD, USA (2001).
26. Viswanathan C, Bansal S, Booth B et al. Workshop/conference report-quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. AAPS J. 9(1), E30-E42 (2007). (Pubitemid 46296546)
27. Snyder LR, Kirkland JJ, Glajch JL. Practical HPLC Method Development (2nd Edition). John Wiley & Sons Inc., NY, USA, 47-49 (1997).